Transform Your Portfolio With This Simple Morning Trade!

Hi, I’m trading expert Dave Aquino and I want to show you how to take advantage of a trading opportunity happening nearly every morning at 9:30 EST.

My free guide, “How To Master The Retirement Trade” will show you exactly why traders in the know want to keep this trade a secret.

CRBU Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 9.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $143,506.37

Caribou Biosciences Insider Trading History Chart

Caribou Biosciences Share Price & Price History

^$5.09

▼ -0.17 (-3.23%)

As of 09/22/2023 01:00 AM ET

Days: 30 | 90 | 365

Successful Options Trading Begins With…

From Tradewins | Ad

Options trading expert Wendy Kirkland’s free guide reveals the options trading principles that are as easy to implement as they are to learn and how using them could earn you thousands in extra income each month!

Download the guide here and see the difference!

Caribou Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/19/2023	Syed Ali-Aamir Rizvi	Insider	Sell	5,627	$6.31	$35,506.37	59,373
10/6/2022	Ryan Fischesser	VP	Sell	10,000	$10.80	$108,000.00	110,366
8/25/2022	Steven Kanner	Insider	Sell	43,248	$11.22	$485,242.56	302,059
1/11/2022	Ryan Fischesser	VP	Buy	7,387	$4.00	$29,548.00
12/20/2021	Ryan Fischesser	VP	Buy	1,136	$2.69	$3,055.84
12/7/2021	Barbara G. McClung	Insider	Buy	6,127	$2.69	$16,481.63
10/20/2021	Barbara G. McClung	Insider	Buy	9,219	$2.69	$24,799.11
10/12/2021	Steven Kanner	Insider	Buy	114,860	$1.92	$220,531.20
10/11/2021	Ryan Fischesser	VP	Buy	1,746	$2.69	$4,696.74

Successful Options Trading Begins With…

From Tradewins | Ad

Download the guide here and see the difference!

SEC Filings (Institutional Ownership Changes) for Caribou Biosciences (NASDAQ:CRBU)

59.16% of Caribou Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Caribou Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/21/2023	Baystate Wealth Management LLC	12,903	$55K	0.0%	N/A	0.015%
8/21/2023	California State Teachers Retirement System	18,923	$80K	0.0%	-70.3%	0.021%
8/16/2023	Nuveen Asset Management LLC	232,878	$0.99M	0.0%	-20.5%	0.380%
8/15/2023	Alliancebernstein L.P.	67,950	$0.29M	0.0%	+71.6%	0.111%
8/15/2023	Wells Fargo & Company MN	23,356	$99K	0.0%	-53.8%	0.038%
8/15/2023	Public Employees Retirement System of Ohio	37,700	$0.16M	0.0%	N/A	0.061%
8/15/2023	Walleye Capital LLC	494,112	$2.10M	0.0%	N/A	0.805%
8/15/2023	Walleye Trading LLC	23,204	$99K	0.0%	N/A	0.038%
8/15/2023	Y Intercept Hong Kong Ltd	44,155	$0.19M	0.0%	N/A	0.072%
8/15/2023	Goldman Sachs Group Inc.	270,641	$1.15M	0.0%	-13.7%	0.441%
8/15/2023	Royal Bank of Canada	8,106	$34K	0.0%	+52.3%	0.013%
8/14/2023	Ergoteles LLC	12,500	$53K	0.0%	N/A	0.020%
8/14/2023	Tower Research Capital LLC TRC	6,871	$29K	0.0%	+88.1%	0.011%
8/14/2023	State Street Corp	1,070,146	$4.55M	0.0%	-68.1%	1.744%
8/14/2023	Nuveen Asset Management LLC	232,878	$0.99M	0.0%	-20.5%	0.380%
8/14/2023	Granahan Investment Management LLC	126,297	$0.54M	0.0%	+3.8%	0.206%
8/14/2023	Prelude Capital Management LLC	23,900	$0.10M	0.0%	N/A	0.039%
8/11/2023	BlackRock Inc.	4,764,609	$20.25M	0.0%	+0.2%	7.765%
8/11/2023	SVB Financial Group	20,714	$88K	0.2%	-25.0%	0.034%
8/11/2023	Stansberry Asset Management LLC	253,552	$0.30M	0.1%	+257.8%	0.413%
8/11/2023	State Board of Administration of Florida Retirement System	16,150	$69K	0.0%	N/A	0.026%
8/11/2023	The Manufacturers Life Insurance Company	24,662	$0.11M	0.0%	+11.7%	0.040%
8/11/2023	Trexquant Investment LP	88,867	$0.38M	0.0%	N/A	0.145%
8/11/2023	Geode Capital Management LLC	1,111,551	$4.72M	0.0%	+3.9%	1.812%
8/11/2023	JPMorgan Chase & Co.	592,182	$2.52M	0.0%	-1.8%	0.965%
8/11/2023	Penserra Capital Management LLC	25,223	$0.11M	0.0%	+33.5%	0.041%
8/11/2023	Northern Trust Corp	531,984	$2.26M	0.0%	+0.6%	0.867%
8/11/2023	ExodusPoint Capital Management LP	39,350	$0.17M	0.0%	N/A	0.064%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	251,669	$1.07M	0.0%	+12.7%	0.410%
8/10/2023	Charles Schwab Investment Management Inc.	412,625	$1.75M	0.0%	+0.5%	0.672%
8/10/2023	Citigroup Inc.	26,350	$0.11M	0.0%	-86.5%	0.043%
8/9/2023	Dimensional Fund Advisors LP	130,680	$0.56M	0.0%	-38.7%	0.213%
8/7/2023	Principal Financial Group Inc.	18,971	$81K	0.0%	+20.1%	0.031%
8/3/2023	Barclays PLC	18,211	$77K	0.0%	-82.0%	0.021%
8/3/2023	Bank of New York Mellon Corp	204,001	$0.87M	0.0%	+9.7%	0.332%
8/2/2023	Baystate Wealth Management LLC	12,903	$55K	0.0%	N/A	0.021%
7/25/2023	Raymond James & Associates	210,586	$0.90M	0.0%	+287.2%	0.343%
7/25/2023	Assenagon Asset Management S.A.	762,098	$3.24M	0.0%	-9.6%	1.242%
7/20/2023	Exchange Traded Concepts LLC	29,068	$0.12M	0.0%	N/A	0.047%
7/6/2023	Green Alpha Advisors LLC	105,826	$0.45M	0.3%	+25.3%	0.172%
5/23/2023	Royce & Associates LP	14,700	$78K	0.0%	+38.7%	0.024%
5/18/2023	JPMorgan Chase & Co.	602,978	$3.20M	0.0%	+0.5%	0.983%
5/18/2023	New York State Common Retirement Fund	15,071	$80K	0.0%	-75.6%	0.025%
5/18/2023	International Biotechnology Trust PLC	457,892	$2.43M	0.7%	+77.6%	0.746%
5/16/2023	Susquehanna Fundamental Investments LLC	43,379	$0.23M	0.0%	-16.0%	0.071%
5/16/2023	State Street Corp	3,355,292	$17.82M	0.0%	+4.9%	5.468%
5/16/2023	Squarepoint Ops LLC	71,578	$0.38M	0.0%	-45.6%	0.117%
5/16/2023	Geode Capital Management LLC	1,069,624	$5.68M	0.0%	+3.7%	1.743%
5/16/2023	BSW Wealth Partners	13,464	$71K	0.0%	N/A	0.022%
5/15/2023	Deutsche Bank AG	34,849	$0.19M	0.0%	+39.2%	0.057%
5/15/2023	Price T Rowe Associates Inc. MD	10,546	$56K	0.0%	N/A	0.017%
5/15/2023	Granahan Investment Management LLC	121,650	$0.65M	0.0%	-47.2%	0.198%
5/15/2023	XTX Topco Ltd	15,344	$81K	0.0%	-41.9%	0.025%
5/12/2023	Renaissance Technologies LLC	77,700	$0.41M	0.0%	N/A	0.127%
5/12/2023	Bruce & Co. Inc.	100,000	$0.53M	0.1%	N/A	0.163%
5/12/2023	Candriam S.C.A.	85,556	$0.42M	0.0%	N/A	0.139%
5/12/2023	BlackRock Inc.	4,754,563	$25.25M	0.0%	+0.7%	7.748%
5/12/2023	Long Focus Capital Management LLC	48,750	$0.26M	0.0%	-25.0%	0.079%
5/12/2023	Bank of America Corp DE	2,632,385	$13.98M	0.0%	+42.8%	4.290%
5/12/2023	UBS Group AG	139,755	$0.74M	0.0%	-28.2%	0.228%
5/12/2023	NewEdge Advisors LLC	5,100	$27K	0.0%	+187.3%	0.008%
5/12/2023	Dimensional Fund Advisors LP	213,283	$1.13M	0.0%	+75.1%	0.348%
5/12/2023	Charles Schwab Investment Management Inc.	410,449	$2.18M	0.0%	+1.4%	0.669%
5/12/2023	Profund Advisors LLC	43,585	$0.23M	0.0%	N/A	0.071%
5/11/2023	RMB Capital Management LLC	74,629	$0.40M	0.0%	+41.4%	0.122%
5/11/2023	Rhumbline Advisers	87,473	$0.46M	0.0%	+2.6%	0.143%
5/11/2023	Citigroup Inc.	195,695	$1.04M	0.0%	+89.8%	0.319%
5/11/2023	E Fund Management Co. Ltd.	13,274	$70K	0.0%	+19.7%	0.022%
5/10/2023	Credit Suisse AG	58,862	$0.31M	0.0%	+13.2%	0.096%
5/10/2023	Pictet Asset Management SA	2,066,176	$10.97M	0.0%	-19.1%	3.368%
5/10/2023	Swiss National Bank	105,300	$0.56M	0.0%	-10.4%	0.172%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	79,150	$0.42M	0.0%	+78.4%	0.129%
5/9/2023	Bank of New York Mellon Corp	185,994	$0.99M	0.0%	-1.8%	0.303%
5/5/2023	Prime Capital Investment Advisors LLC	26,331	$0.14M	0.0%	N/A	0.043%
5/4/2023	Barclays PLC	101,192	$0.54M	0.0%	-15.7%	0.165%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	223,237	$1.19M	0.0%	+5.0%	0.364%
5/4/2023	Royce & Associates LP	14,700	$78K	0.0%	+38.7%	0.024%
5/3/2023	Jump Financial LLC	27,200	$0.14M	0.0%	-36.2%	0.044%
4/28/2023	SG Americas Securities LLC	22,295	$0.12M	0.0%	-12.1%	0.036%
4/24/2023	Penserra Capital Management LLC	18,890	$100K	0.0%	+34.9%	0.031%
4/18/2023	Assenagon Asset Management S.A.	843,025	$4.48M	0.0%	-1.4%	1.375%
4/14/2023	Raymond James & Associates	54,382	$0.29M	0.0%	N/A	0.089%
4/6/2023	Green Alpha Advisors LLC	84,467	$0.45M	0.3%	+12.5%	0.138%
2/16/2023	Alliancebernstein L.P.	35,300	$0.22M	0.0%	+18.5%	0.058%
2/15/2023	Stansberry Asset Management LLC	70,004	$0.44M	0.1%	+3.5%	0.115%
2/15/2023	State of Wisconsin Investment Board	46,674	$0.29M	0.0%	-6.0%	0.077%
2/15/2023	Susquehanna Fundamental Investments LLC	51,613	$0.32M	0.0%	N/A	0.085%
2/15/2023	SVB Financial Group	47,051	$0.30M	0.8%	N/A	0.077%
2/15/2023	Squarepoint Ops LLC	131,558	$0.83M	0.0%	N/A	0.216%
2/15/2023	Millennium Management LLC	240,043	$1.51M	0.0%	+1.7%	0.394%
2/15/2023	Morgan Stanley	1,229,167	$7.72M	0.0%	+1.2%	2.015%
2/15/2023	Norges Bank	216,300	$1.36M	0.0%	N/A	0.355%
2/15/2023	E Fund Management Co. Ltd.	11,090	$70K	0.0%	N/A	0.018%
2/15/2023	Alkeon Capital Management LLC	1,058,603	$6.65M	0.0%	-13.4%	1.735%
2/15/2023	Avidity Partners Management LP	2,882,600	$18.10M	0.4%	-9.1%	4.726%
2/14/2023	Point72 Asset Management L.P.	289,739	$1.82M	0.0%	N/A	0.475%
2/14/2023	Vident Investment Advisory LLC	15,481	$97K	0.0%	-15.5%	0.025%
2/14/2023	Alpine Global Management LLC	17,442	$0.11M	0.0%	N/A	0.029%
2/14/2023	Two Sigma Investments LP	121,924	$0.77M	0.0%	N/A	0.200%
2/14/2023	Granahan Investment Management LLC	230,341	$1.45M	0.0%	-3.3%	0.378%

Data available starting January 2016

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.

Today's Range

Now: $5.09

$5.06

$5.29

50 Day Range

MA: $6.30

$5.09

$7.31

52 Week Range

Now: $5.09

$3.96

$11.52

Volume

1,056,728 shs

Average Volume

2,115,357 shs

Market Capitalization

$449.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Who are the company insiders with the largest holdings of Caribou Biosciences?: Caribou Biosciences' top insider shareholders include:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Syed Ali-Aamir Rizvi (Insider)
Barbara G Mcclung (Insider)
Learn More about top insider investors at Caribou Biosciences.
Who are the major institutional investors of Caribou Biosciences?: Caribou Biosciences' top institutional shareholders include:
BlackRock Inc. — 7.77%
Geode Capital Management LLC — 1.81%
State Street Corp — 1.74%
Assenagon Asset Management S.A. — 1.24%
JPMorgan Chase & Co. — 0.97%
Northern Trust Corp — 0.87%
Learn More about top institutional investors of Caribou Biosciences stock.
Which institutional investors are selling Caribou Biosciences stock?: In the last quarter, CRBU stock was sold by these institutional investors:
State Street Corp
Citigroup Inc.
Barclays PLC
Dimensional Fund Advisors LP
Assenagon Asset Management S.A.
Nuveen Asset Management LLC
Nuveen Asset Management LLC
California State Teachers Retirement System
Within the previous year, company insiders that have sold Caribou Biosciences company stock include:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Learn More investors selling Caribou Biosciences stock.
Which institutional investors are buying Caribou Biosciences stock?: During the previous quarter, CRBU stock was purchased by institutional investors including:
Walleye Capital LLC
Stansberry Asset Management LLC
Raymond James & Associates
Trexquant Investment LP
Y Intercept Hong Kong Ltd
Geode Capital Management LLC
ExodusPoint Capital Management LP
Public Employees Retirement System of Ohio
Within the last year, these company insiders have bought Caribou Biosciences stock:
Steven Kanner (Insider)
Ryan Fischesser (VP)
Syed Ali-Aamir Rizvi (Insider)
Learn More investors buying Caribou Biosciences stock.